Haojie Jin

Kunming University of Science and Technology — China

Medicine · Health Sciences

36h-index6.6kcitations139works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(21), Cancer, Hypoxia, and Metabolism(15), Cancer-related molecular mechanisms research(14), RNA modifications and cancer(12), Circular RNAs in diseases(9)

Publications139 total

Obesity and mortality in KDIGO stage 3 acute kidney injury: a machine learning-driven retrospective cohort study
BMC Nephrology·2025Open Access
Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D
Cell Reports·2025Open Access
Personalized management of metabolic dysfunction-associated steatotic liver disease
iLiver·2025· 1 citedOpen Access
Prognostic implications of adverse events associated with CAR-T cell therapy: a population-based global observational study
EClinicalMedicine·2025Open Access
BAY 11-7082 Ubiquitinates EGFR and Induces Apoptosis in SHH-MB via PI3K-AKT and STAT3 Pathways
2025Open Access
CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma
Proceedings of the National Academy of Sciences·2025Open Access
Patient-Centered Outpatient Process Optimization System Based on Intelligent Guidance in a Large Tertiary Hospital in China: Implementation Report
JMIR Medical Informatics·2025Open Access
Superior elevated-temperature mechanical properties driven by TaC content in near-eutectic Re0.1Ta1.6W0.6(TaC)x composites
Journal of Alloys and Compounds·2025· 2 cited
Living Environment and Intrinsic Capacity among Chinese Older Adults: A cross-sectional study
2025Open Access
Genome-wide Chromosome-specific Aneuploidy Engineering and Phenotypic Characterization with CRISPR-Taiji
2025Open Access
PRMT1-mediated modification of H4R3me2a promotes liver cancer progression by enhancing the transcriptional activity of SOX18
Hepatology Communications·2025· 2 citedOpen Access
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients
Nature Communications·2025· 3 citedOpen Access
Multifunctional Bimetallic Nanoreactors for Integrative Host‐Pathogen Analysis Toward Bloodstream Infection Diagnosis
Advanced Functional Materials·2025· 3 cited
Combination locoregional and systemic therapies in hepatocellular carcinoma
˜The œLancet. Gastroenterology & hepatology·2025· 46 cited
Interpretable machine learning-derived nomogram model for early detection of persistent diarrhea in Salmonella typhimurium enteritis: a propensity score matching based case-control study
BMC Infectious Diseases·2025Open Access
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Signal Transduction and Targeted Therapy·2025· 174 citedOpen Access
Triple knockdown of <i>CD11a</i> , <i>CD49d</i> , and <i>PSGL1</i> in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
Science Translational Medicine·2025· 9 cited
Microstructure and Tribological Behavior over a Wide Temperature Range of TiCrTaMoSi-Based Composites Fabricated via Spark Plasma Sintering
SSRN Electronic Journal·2025Open Access
Perturbation of mRNA splicing in liver cancer: insights, opportunities and challenges
Gut·2024· 6 cited
Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial
Signal Transduction and Targeted Therapy·2024· 15 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Wenxin Qin(38), Cun Wang(27), Guang‐Zhi Jin(15), Siying Wang(14), Ming Yao(14), René Bernards(13), Roderick L. Beijersbergen(11), Cor Lieftink(10), Yurong Zhang(10), Dishui Gu(10), Chengtao Yu(9), Chen Yang(9), Zhuoan Cheng(8), Hui Wang(8), Jia He(8), Fangyu Zhao(8), Liqin Wang(8), Haoyu Ruan(8), Botai Li(7), Yuanyuan Lv(7)